Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
87.04 USD | +0.09% | -3.19% | +14.33% |
Apr. 17 | Baird Adjusts Edwards Lifesciences Price Target to $102 From $100 | MT |
Apr. 17 | Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.33% | 52.34B | |
+6.09% | 209B | |
+9.03% | 175B | |
+9.71% | 131B | |
+17.99% | 99.98B | |
-1.06% | 61.12B | |
-4.15% | 46.5B | |
-1.81% | 39.24B | |
+10.19% | 38.47B | |
+6.10% | 26.49B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences : Goldman Sachs Adjusts Edwards Lifesciences' Price Target to $105 from $93, Keeps Neutral Rating